Overview

Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The investigators hope that after this research, two different treatment methods' curative effects for advanced gastric cancer can be assessed. One is continuous use of apatinib, the other is 5 days' continuous use and 2 days' off of apatinib.
Phase:
Phase 2
Details
Lead Sponsor:
Anhui Provincial Hospital
Treatments:
Apatinib
Docetaxel